Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):